JOP20200039A1 - مُستحضر صيدلي يشتمل على hcg مأشوب - Google Patents

مُستحضر صيدلي يشتمل على hcg مأشوب

Info

Publication number: JOP20200039A1
Authority: JO; Jordan
Prior art keywords: pharmaceutical preparation; preparation containing; containing recombinant; recombinant hcg; hcg
Prior art date: 2009-10-05

Application number

JOP/2020/0039A

Other languages

Arabic (ar)

English (en)

Inventor

Cottingham Ian

Plaksin Daniel

Boyd White Richard

Original Assignee

Ferring Int Center Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-10-05

Filing date

2020-02-17

Publication date

2022-10-30

2020-02-17 Application filed by Ferring Int Center Sa filed Critical Ferring Int Center Sa

2022-10-30 Publication of JOP20200039A1 publication Critical patent/JOP20200039A1/ar

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Reproductive Health (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Diabetes (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

JOP/2020/0039A 2009-10-05 2020-02-17 مُستحضر صيدلي يشتمل على hcg مأشوب JOP20200039A1 (ar)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP09252360		2009-10-05

Publications (1)

Publication Number	Publication Date
JOP20200039A1 true JOP20200039A1 (ar)	2022-10-30

Family

ID=41471027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JOP/2020/0039A JOP20200039A1 (ar)	2009-10-05	2020-02-17	مُستحضر صيدلي يشتمل على hcg مأشوب

Country Status (25)

Country	Link
US (5)	US8975226B2 (pt)
EP (2)	EP3611185B1 (pt)
JP (6)	JP6176924B2 (pt)
KR (7)	KR20230012104A (pt)
CN (1)	CN107050434B (pt)
AR (2)	AR079876A1 (pt)
AU (1)	AU2010304922B2 (pt)
BR (1)	BR112012007990A2 (pt)
CA (1)	CA2776790A1 (pt)
DK (1)	DK2486051T3 (pt)
ES (2)	ES3036152T3 (pt)
HR (1)	HRP20200941T1 (pt)
HU (1)	HUE050793T2 (pt)
IL (3)	IL218548A (pt)
IN (1)	IN2012DN02073A (pt)
JO (1)	JOP20200039A1 (pt)
LT (1)	LT2486051T (pt)
MX (1)	MX2012003951A (pt)
PL (1)	PL2486051T3 (pt)
PT (1)	PT2486051T (pt)
RS (1)	RS60413B1 (pt)
RU (2)	RU2724528C2 (pt)
SI (1)	SI2486051T1 (pt)
TW (2)	TWI532495B (pt)
WO (1)	WO2011042688A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI488640B (zh)	2008-04-16	2015-06-21	菲瑞茵國際中心股份有限公司	藥學製劑
TWI532495B (zh) *	2009-10-05	2016-05-11	菲瑞茵國際中心股份有限公司	藥學製劑
US9757469B2 (en) *	2011-03-31	2017-09-12	Ferring B.V.	Pharmaceutical preparation
EP2717904A1 (en) *	2011-06-06	2014-04-16	Ferring BV	Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) *	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض
AU2012340501A1 (en) *	2011-12-19	2013-07-11	Grifols, S.A.	Compositions, methods, and kits for preparing sialylated recombinant proteins
US10144923B2 (en)	2012-12-10	2018-12-04	Seikagaku Corporation	Recombinant Factor C and method for producing the same, and method for measuring endotoxin
CN107429237B (zh) *	2014-12-22	2021-09-28	豪夫迈·罗氏有限公司	Cmp依赖性的唾液酸酶活性
US10464984B2 (en) *	2015-04-24	2019-11-05	Ferring B.V.	Optimized nucleic acid sequences coding for the alpha-chain of human chorionic gonadotropin
CA2990311A1 (en)	2015-06-26	2016-12-29	Ferring B.V.	Methods of purification and/or viral inactivation
RS66871B1 (sr)	2018-04-30	2025-06-30	Ferring Bv	Kompozicija za kontrolisanu stimulaciju jajnika
US20210244821A1 (en) *	2020-02-05	2021-08-12	Novartis Ag	Cho cell expressed het il-15
CN116199742B (zh) *	2022-07-06	2025-01-24	华兰基因工程有限公司	一种重组人绒毛膜促性腺激素Fc融合蛋白制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4840896A (en) *	1983-11-02	1989-06-20	Integrated Genetics, Inc.	Heteropolymeric protein
DK49987A (da) *	1987-01-30	1988-07-31	Nordisk Gentofte	Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
IT1206302B (it)	1987-06-26	1989-04-14	Serono Cesare Ist Ricerca	Ormone follicolo-stimolante urinario
JP4165718B2 (ja) *	1995-03-21	2008-10-15	ラボラトワールセローノソシエテアノニム	ｈＣＧ液体製剤
IL122732A0 (en) *	1997-01-15	1998-08-16	Akzo Nobel Nv	Liquid gonadotropin-containing formulation its preparation and a device containing same
ATE335000T1 (de)	1997-06-25	2006-08-15	Applied Research Systems	Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
US6500627B1 (en)	1998-02-03	2002-12-31	The Trustees Of Columbia University In The City Of New York	Methods for predicting pregnancy outcome in a subject by HCG assay
WO2003050286A1 (en) *	2001-10-29	2003-06-19	Crucell Holland B.V.	Methods and means for producing proteins with predetermined post-translational modifications
PT1176976E (pt)	1999-05-07	2006-11-30	Applied Research Systems	Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias.
ATE406378T1 (de)	2000-02-22	2008-09-15	Serono Lab	Verfahren zur reinigung vom recombinantem hcg mit spezifischer bioaktivität
CN100536912C (zh)	2001-09-12	2009-09-09	雪兰诺实验室有限公司	人绒毛膜促性腺激素在控制性超排卵中的应用
MEP38608A (en) *	2001-10-22	2011-02-10	Merck Serono Sa	Gonadotrophins for folliculogenesis
CA2465007C (en) *	2001-10-29	2012-01-17	Crucell Holland B.V.	Methods and means for producing proteins with predetermined post-translational modifications
CN1374525A (zh) *	2001-12-31	2002-10-16	陕西超英生物医学研究开发有限公司	一种抗体芯片、其制备技术及其检测方法
AU2004226353A1 (en)	2003-04-01	2004-10-14	Laboratoires Serono Sa	Inhibitors of phosphodiesterases in infertility
SG155777A1 (en) *	2003-04-09	2009-10-29	Neose Technologies Inc	Glycopegylation methods and proteins/peptides produced by the methods
US20040248784A1 (en)	2003-06-03	2004-12-09	Marco Filicori	Unitary combinations of FSH and hCG
JP4518464B2 (ja)	2003-06-30	2010-08-04	ミヨシ油脂株式会社	紙類処理剤及び紙類
US8017388B2 (en) *	2003-08-18	2011-09-13	Glycotope Gmbh	Tumour cell lines and uses thereof
ATE476666T1 (de) *	2004-02-04	2010-08-15	Centre Nat Rech Scient	Verfahren zur identifizierung von glykoformspezifischen antikörpern
JP4913604B2 (ja) *	2004-02-13	2012-04-11	グリコトープゲーエムベーハー	高活性糖タンパク質−製造条件、及びその効率的製造方法
EP1861124A2 (en) *	2005-03-11	2007-12-05	Fresenius Kabi Deutschland GmbH	Production of bioactive glycoproteins from inactive starting materials by conjugation with hydroxyalkylstarch
US20070033927A1 (en) *	2005-08-15	2007-02-15	Homby Michael J	Automotive diesel exhaust HC dosing valve
RU2309411C2 (ru) *	2005-11-24	2007-10-27	Ростовский НИИ акушерства и педиатрии МЗ РФ	Способ отбора пациенток с синдромом "пустых" фолликулов для проведения программы эко и пэ донорскими ооцитами
KR100809945B1 (ko) *	2006-02-01	2008-03-05	대한민국	인체장내정상세균총 특이반응 ｄｎａ칩 및 이를 이용한인체장내정상세균총의 변화에 의한 인체 위해성의 평가방법
US20080248959A1 (en) *	2006-07-21	2008-10-09	Neose Technologies, Inc.	Glycosylation of peptides via o-linked glycosylation sequences
JP2010505874A (ja) *	2006-10-03	2010-02-25	ノヴォノルディスクアー／エス	ポリペプチドコンジュゲートの精製方法
TWI488640B (zh) *	2008-04-16	2015-06-21	菲瑞茵國際中心股份有限公司	藥學製劑
TWI532495B (zh)	2009-10-05	2016-05-11	菲瑞茵國際中心股份有限公司	藥學製劑
US9757469B2 (en) *	2011-03-31	2017-09-12	Ferring B.V.	Pharmaceutical preparation
JO3092B1 (ar) *	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض

2010
- 2010-09-27 TW TW099132570A patent/TWI532495B/zh not_active IP Right Cessation
- 2010-09-27 TW TW104140348A patent/TWI604850B/zh active
- 2010-10-04 JP JP2012532657A patent/JP6176924B2/ja active Active
- 2010-10-04 KR KR1020237001308A patent/KR20230012104A/ko active Pending
- 2010-10-04 KR KR1020127008827A patent/KR101804479B1/ko active Active
- 2010-10-04 AU AU2010304922A patent/AU2010304922B2/en active Active
- 2010-10-04 ES ES19190372T patent/ES3036152T3/es active Active
- 2010-10-04 DK DK10763000.6T patent/DK2486051T3/da active
- 2010-10-04 IN IN2073DEN2012 patent/IN2012DN02073A/en unknown
- 2010-10-04 EP EP19190372.3A patent/EP3611185B1/en active Active
- 2010-10-04 EP EP10763000.6A patent/EP2486051B1/en active Active
- 2010-10-04 PT PT107630006T patent/PT2486051T/pt unknown
- 2010-10-04 KR KR1020177034392A patent/KR20170133531A/ko not_active Withdrawn
- 2010-10-04 KR KR1020217037028A patent/KR102489143B1/ko active Active
- 2010-10-04 RU RU2016118236A patent/RU2724528C2/ru active
- 2010-10-04 KR KR1020217003233A patent/KR20210014767A/ko not_active Ceased
- 2010-10-04 PL PL10763000T patent/PL2486051T3/pl unknown
- 2010-10-04 HU HUE10763000A patent/HUE050793T2/hu unknown
- 2010-10-04 SI SI201032015T patent/SI2486051T1/sl unknown
- 2010-10-04 CA CA2776790A patent/CA2776790A1/en active Pending
- 2010-10-04 KR KR1020197007226A patent/KR101987982B1/ko not_active Expired - Fee Related
- 2010-10-04 WO PCT/GB2010/001854 patent/WO2011042688A1/en not_active Ceased
- 2010-10-04 MX MX2012003951A patent/MX2012003951A/es active IP Right Grant
- 2010-10-04 HR HRP20200941TT patent/HRP20200941T1/hr unknown
- 2010-10-04 LT LTEP10763000.6T patent/LT2486051T/lt unknown
- 2010-10-04 RS RS20200698A patent/RS60413B1/sr unknown
- 2010-10-04 ES ES10763000T patent/ES2798258T3/es active Active
- 2010-10-04 US US13/500,274 patent/US8975226B2/en active Active
- 2010-10-04 RU RU2012112907/10A patent/RU2588650C2/ru active
- 2010-10-04 KR KR1020197016021A patent/KR102213154B1/ko active Active
- 2010-10-04 CN CN201610832288.8A patent/CN107050434B/zh active Active
- 2010-10-04 BR BR112012007990A patent/BR112012007990A2/pt not_active Application Discontinuation
- 2010-10-05 AR ARP100103608A patent/AR079876A1/es not_active Application Discontinuation
2012
- 2012-03-08 IL IL218548A patent/IL218548A/en active IP Right Grant
2014
- 2014-05-21 US US14/283,904 patent/US9676835B2/en active Active
2015
- 2015-11-09 JP JP2015219480A patent/JP6310440B2/ja active Active
2017
- 2017-02-23 IL IL250733A patent/IL250733B/en active IP Right Grant
- 2017-05-03 US US15/586,010 patent/US10526390B2/en active Active
- 2017-10-24 JP JP2017205012A patent/JP6580104B2/ja active Active
2019
- 2019-06-20 IL IL267556A patent/IL267556A/en unknown
- 2019-08-27 JP JP2019154226A patent/JP7292153B2/ja active Active
- 2019-12-10 US US16/709,810 patent/US11292824B2/en active Active
2020
- 2020-02-17 JO JOP/2020/0039A patent/JOP20200039A1/ar unknown
2021
- 2021-07-12 JP JP2021114833A patent/JP7196244B2/ja active Active
2022
- 2022-03-30 US US17/709,296 patent/US12234272B2/en active Active
- 2022-05-27 AR ARP220101408A patent/AR125991A2/es not_active Application Discontinuation
2023
- 2023-02-22 JP JP2023025781A patent/JP2023075144A/ja active Pending

Also Published As

Publication number	Publication date
IL250733B (en)	2019-07-31
US20200247863A1 (en)	2020-08-06
AU2010304922B2 (en)	2014-11-06
CN107050434B (zh)	2021-07-27
MX2012003951A (es)	2012-05-29
KR20170133531A (ko)	2017-12-05
US11292824B2 (en)	2022-04-05
KR20230012104A (ko)	2023-01-25
KR102213154B1 (ko)	2021-02-05
RU2012112907A (ru)	2013-11-10
TW201632198A (zh)	2016-09-16
RU2016118236A3 (pt)	2019-09-18
US12234272B2 (en)	2025-02-25
US20140249082A1 (en)	2014-09-04
AR079876A1 (es)	2012-02-29
KR20210014767A (ko)	2021-02-09
LT2486051T (lt)	2020-07-10
IL267556A (en)	2019-08-29
KR20120094909A (ko)	2012-08-27
TWI604850B (zh)	2017-11-11
HRP20200941T1 (hr)	2020-09-18
CN102549011A (zh)	2012-07-04
US20130023476A1 (en)	2013-01-24
IL218548A0 (en)	2012-05-31
RU2016118236A (ru)	2018-10-29
JP6580104B2 (ja)	2019-09-25
AU2010304922A1 (en)	2012-03-29
DK2486051T3 (da)	2020-06-22
KR102489143B1 (ko)	2023-01-13
JP2020000246A (ja)	2020-01-09
US20180030107A1 (en)	2018-02-01
ES2798258T3 (es)	2020-12-10
EP2486051B1 (en)	2020-03-25
JP2023075144A (ja)	2023-05-30
JP2018076296A (ja)	2018-05-17
RU2724528C2 (ru)	2020-06-23
BR112012007990A2 (pt)	2017-07-25
JP2016074680A (ja)	2016-05-12
HUE050793T2 (hu)	2021-01-28
IL250733A0 (en)	2017-04-30
IN2012DN02073A (pt)	2015-08-21
JP6176924B2 (ja)	2017-08-09
JP2021176867A (ja)	2021-11-11
US8975226B2 (en)	2015-03-10
KR101987982B1 (ko)	2019-06-11
WO2011042688A1 (en)	2011-04-14
PL2486051T3 (pl)	2020-09-07
JP7196244B2 (ja)	2022-12-26
IL218548A (en)	2017-03-30
PT2486051T (pt)	2020-06-17
CN107050434A (zh)	2017-08-18
KR20210141771A (ko)	2021-11-23
TWI532495B (zh)	2016-05-11
RU2588650C2 (ru)	2016-07-10
JP7292153B2 (ja)	2023-06-16
KR101804479B1 (ko)	2017-12-05
US20220340634A1 (en)	2022-10-27
RS60413B1 (sr)	2020-07-31
US10526390B2 (en)	2020-01-07
AR125991A2 (es)	2023-08-30
JP6310440B2 (ja)	2018-04-11
EP2486051A1 (en)	2012-08-15
JP2013506708A (ja)	2013-02-28
US9676835B2 (en)	2017-06-13
KR20190067256A (ko)	2019-06-14
CA2776790A1 (en)	2011-04-14
EP3611185A1 (en)	2020-02-19
TW201113030A (en)	2011-04-16
SI2486051T1 (sl)	2020-08-31
KR20190028823A (ko)	2019-03-19
ES3036152T3 (en)	2025-09-15
EP3611185B1 (en)	2025-04-30

Publication	Publication Date	Title
JOP20200039A1 (ar)	2022-10-30	مُستحضر صيدلي يشتمل على hcg مأشوب
JOP20180102B1 (ar)	2022-03-14	مركب صيدلاني
HUE062860T2 (hu)	2023-12-28	Magas koncentrációjú gyógyszerészeti készítmények
MX2018012166A (es)	2020-09-02	Dosificacion oral de compuestos peptido similar al glaucon-1 (glp-1).
MX393345B (es)	2025-03-24	Composiciones farmaceuticas de moduladores c-met.
EA201490070A1 (ru)	2014-05-30	Коантагонисты глюкагонового рецептора/glp-1-рецептора
MX2012007098A (es)	2012-07-20	Derivados fenolicos y su uso farmaceutico o cosmetico.
MX2012007161A (es)	2012-07-03	Derivados fenolicos y su uso farmaceutico o cosmetico.
DK3620175T3 (da)	2025-01-06	Højkoncentrerede antistofformuleringer
EA201390254A1 (ru)	2013-08-30	Модифицированные полипептиды релаксина и их применение
IL236315A (en)	2016-11-30	Compositions comprising purified recombinant iduronate-2-sulfatase
UA107476C2 (uk)	2015-01-12	Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів
EA201500245A1 (ru)	2015-07-30	Твердый фармацевтический препарат, который содержит левотироксин
EA201390955A1 (ru)	2013-11-29	Слитый белок robo1-fc для применения в лечении гепатокарциномы
EP3003360A4 (en)	2017-04-26	High potency pancreatin pharmaceutical compositions
BR112013019687A2 (pt)	2017-06-13	antraquinona contendo preparações/formulações de lignina.
EA201300733A1 (ru)	2013-12-30	Рекомбинантные микобактерии в качестве вакцины
PT2668959E (pt)	2015-02-05	Compostos imunogénicos compreendendo o péptido gp41 do vih acoplado à proteína transportadora crm197
MA32321B1 (fr)	2011-05-02	Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
TR201100148A2 (tr)	2012-07-23	Stabil akarboz förmülasyonları.
MX2015012905A (es)	2016-06-16	Formulaciones de factor viii recombinantes.
MY165088A (en)	2018-02-28	Pharmaceutical compositions comprising alisporivir
TR201007106A1 (tr)	2012-03-21	Sefpodoksim proksetil formülasyonları.
IT1399492B1 (it)	2013-04-19	Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
TR201009168A2 (tr)	2012-05-21	Suda dağılan sefpodoksim proksetil formülasyonları.